BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28791377)

  • 1. c‑Maf inducing protein inhibits cofilin‑1 activity and alters podocyte cytoskeleton organization.
    Yu L; Ye J; Liu Q; Feng J; Gu X; Sun Q; Lu G
    Mol Med Rep; 2017 Oct; 16(4):4955-4963. PubMed ID: 28791377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein.
    Lu TC; He JC; Wang ZH; Feng X; Fukumi-Tominaga T; Chen N; Xu J; Iyengar R; Klotman PE
    J Biol Chem; 2008 Mar; 283(13):8173-82. PubMed ID: 18234668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner.
    Bondeva T; Wojciech S; Wolf G
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F852-70. PubMed ID: 21734098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fyn-binding protein ADAP supports actin organization in podocytes.
    Wu Z; Blessing NA; Simske JS; Bruggeman LA
    Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29192064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal.
    Huang Z; Zhang L; Chen Y; Zhang H; Yu C; Zhou F; Zhang Z; Jiang L; Li R; Ma J; Li Z; Lai Y; Lin T; Zhao X; Zhang Q; Zhang B; Ye Z; Liu S; Wang W; Liang X; Liao R; Shi W
    BMC Nephrol; 2016 Jul; 17(1):66. PubMed ID: 27389190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of CMIP transcription by WT1 is relevant to podocyte health.
    Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A
    Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
    Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
    Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.
    Hsu HH; Hoffmann S; Endlich N; Velic A; Schwab A; Weide T; Schlatter E; Pavenstädt H
    J Mol Med (Berl); 2008 Dec; 86(12):1379-94. PubMed ID: 18773185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMIP interacts with WT1 and targets it on the proteasome degradation pathway.
    Zhang SY; Fan Q; Moktefi A; Ory V; Audard V; Pawlak A; Ollero M; Sahali D; Henique C
    Clin Transl Med; 2021 Jul; 11(7):e460. PubMed ID: 34323419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nephrin activation by c-mip through Csk-Cbp-Fyn axis plays a critical role in Angiotensin II-induced podocyte damage.
    Yu L; Lin Q; Feng J; Dong X; Chen W; Liu Q; Ye J
    Cell Signal; 2013 Mar; 25(3):581-8. PubMed ID: 23200848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro.
    Lv Z; Hu M; Ren X; Fan M; Zhen J; Chen L; Lin J; Ding N; Wang Q; Wang R
    J Diabetes Res; 2016; 2016():5671803. PubMed ID: 26881253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway.
    Li Z; Lian Z; Ma J; Zhang L; Lian X; Liu S; Xie J; Feng Z; Lin T; Zhang H; Liang X
    Bioengineered; 2021 Dec; 12(1):1138-1149. PubMed ID: 33818281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts.
    Wei C; Banu K; Garzon F; Basgen JM; Philippe N; Yi Z; Liu R; Choudhuri J; Fribourg M; Liu T; Cumpelik A; Wong J; Khan M; Das B; Keung K; Salem F; Campbell KN; Kaufman L; Cravedi P; Zhang W; O'Connell PJ; He JC; Murphy B; Menon MC
    J Am Soc Nephrol; 2018 Nov; 29(11):2641-2657. PubMed ID: 30341149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin controls cytoskeleton reorganization and filtration barrier permeability via the PKGIα-Rac1-RhoA crosstalk in cultured rat podocytes.
    Rachubik P; Szrejder M; Rogacka D; Typiak M; Audzeyenka I; Kasztan M; Pollock DM; Angielski S; Piwkowska A
    Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119301. PubMed ID: 35642843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling.
    Jeruschke S; Büscher AK; Oh J; Saleem MA; Hoyer PF; Weber S; Nalbant P
    PLoS One; 2013; 8(2):e55980. PubMed ID: 23418489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton.
    Faul C; Asanuma K; Yanagida-Asanuma E; Kim K; Mundel P
    Trends Cell Biol; 2007 Sep; 17(9):428-37. PubMed ID: 17804239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac1 contributes to actin organization in glomerular podocytes.
    Attias O; Jiang R; Aoudjit L; Kawachi H; Takano T
    Nephron Exp Nephrol; 2010; 114(3):e93-e106. PubMed ID: 19955829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture.
    Garg P; Verma R; Cook L; Soofi A; Venkatareddy M; George B; Mizuno K; Gurniak C; Witke W; Holzman LB
    J Biol Chem; 2010 Jul; 285(29):22676-88. PubMed ID: 20472933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes.
    Zhu J; Sun N; Aoudjit L; Li H; Kawachi H; Lemay S; Takano T
    Kidney Int; 2008 Mar; 73(5):556-66. PubMed ID: 18033240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.